News

This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.
Scientific research has gifted us with a range of evidence-based options to protect ourselves from getting infected with HIV.
The field of HIV treatment has witnessed a significant transformation since the mid-1990s with the introduction of combination antiretroviral therapy ...
Lenacapavir has demonstrated enormous potential as a new HIV prevention tool with a 100 per cent efficacy rate and zero ...
Lenacapavir is a major step forward in HIV prevention. With just two injections a year, it is a simple and highly effective ...
There are two ways that HIV patients’ bodies can keep the virus under control after they stop antiretroviral therapy, a new ...
World leaders are dismantling global health programs and cutting back foreign aid. Will an extraordinary new medicine be able ...
The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...
While PrEP tablets are already prescribed around the world to prevent people from contracting HIV, experts in the US hope a ...
The new HIV PrEP option could drastically reduce the number of new cases by offering a new alternative to daily pills or ...
June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections.